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Introduction
Physiotherapy treatment is often used in patients in
intensive care (ICU) for the prevention and treatment of
pulmonary complications such as sputum retention and
atelectasis (Mackenzie et al 1980, Pontpiddan 1985).
Ntoumenopoulos et al (2002) demonstrated in critically ill
patients that physiotherapy treatment was associated with a
reduction in nosocomial pneumonia. In addition, various
components have been shown to improve lung and thorax
compliance, reduce the volume of retained secretions and
improve intrapulmonary shunt (Hodgson et al 2000, Jones
et al 1992, Mackenzie et al 1980, Mackenzie and Shin
1985, Ntoumenopoulos and Greenwood 1996). In
particular, the short term effects of manual hyperinflation
(MHI) using a manual resuscitation bag on pulmonary
compliance, resolution of atelectasis and sputum
production have been well documented (Hodgson et al
2000, Jones et al 1992, Rothen et al 1993, Stiller et al 1990,
1996 and 2000). A recent study demonstrated that
hyperinflation can be performed with equal benefit using a
manual resuscitation bag or a ventilator (Berney and
Denehy 2002).
As with many other routine ICU interventions, however,
this treatment has been associated with an  increase in
metabolic and cardiovascular demand (Cohen et al 1996,
Gormezano and Branthwaite 1972, Harding et al 1993 and
1994, Klein et al 1988, Mathews and Weissman 1990,
Swinamer et al 1987, Weissman et al 1984, Weissman and
Kemper 1993). In critically ill patients, cellular oxygen
consumption (VO
2
) is already increased and peripheral
oxygen (O
2
) extraction capabilities may be impaired
(Clarke 1997, Silance et al 1994). Therefore any reduction
in delivery or increase in O
2
demand, as may occur with
physiotherapy treatment, may predispose the patient to
adverse events (Treacher and Leach 1994).
Previous studies examining the effect of physiotherapy
treatment on VO
2
have failed to differentiate the effects of
this treatment from patient positioning alone, a procedure
that reportedly increases VO
2 
by 31% (Swinamer et al
1987). In addition, the aim of these studies was to
investigate the administration of medication to supress
cardiovascular and metabolic responses using
physiotherapy treatment as a physiological stress. There is,
however, no supporting evidence from controlled trials that
physiotherapy treatment is physiologically stressful. The
purpose of this study was to determine the effect of
physiotherapy treatment on VO
2
mean, MAP and CI in
stable, intubated and ventilated patients compared with
turning the same patient into the side lying position. 
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The purpose of this study was to determine metabolic and haemodynamic changes with and without physiotherapy treatment
in haemodynamically stable, intubated and ventilated patients. This was a prospective, randomised cross-over study. Ten
intubated, ventilated and haemodynamically stable patients underwent a 20 min physiotherapy treatment and a 20 min period
of undisturbed side lying. Mean oxygen consumption (VO2mean) was measured on a minute-to-minute basis by indirect
calorimetry. Mean arterial pressure (MAP) was recorded minutely from the indwelling arterial line and cardiac index (CI) was
calculated from the indwelling pulmonary artery catheter. Time to recovery to within 5% of resting VO2 was also recorded. The
results showed no significant increase in VO2mean with either positioning the patient in side lying or physiotherapy treatment(p = 0.17). Time to recovery to within 5% of baseline VO2 occurred within seven minutes for all patients and there was no
significant difference between either physiotherapy treatment or positioning in side lying (p = 0.63). There were no significant
differences in CI (p = 0.44) or MAP (p = 0.95) during physiotherapy treatment compared with undisturbed side lying. It is
concluded that physiotherapy treatment does not significantly alter VO2mean or MAP and CI in stable intubated and ventilated
patients. [Berney S and Denehy L (2003): The effect of physiotherapy treatment on oxygen consumption and
haemodynamics in patients who are critically ill. Australian Journal of Physiotherapy 49: 99-105]
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Methods
Study population This study was approved by The Austin
Hospital Ethics and Human Research Committee, and
informed consent was obtained from next of kin and from
the treating intensive care physician. Using the results from
Harding et al 1993 (difference in the means VO
2
= 115
mL/min, mean standard deviation = 78 mL/min) with alpha
= 0.05, two tailed paired t-test, for a power > 0.80 the
sample size required was 10 subjects. Ten sequential
patients who met the inclusion criteria were studied.
Patients were included if they a) were intubated and
ventilated; b) had a pulmonary artery and arterial line in
situ; c) were cardiovascularly stable; and d) would receive
physiotherapy as a part of routine care. Patients were
considered cardiovascularly stable if they had a MAP >
75mmHg, with a fluctuation of MAP < 15mmHg with
position change and a CI > 2.3 L/min/m2. Patients were
excluded from the trial if a) they had a fraction of inspired
oxygen (FiO
2
) > 0.6; b) a positive end expiratory pressure
> 10cmH
2
O; c) pulmonary pathology where lung
hyperinflation was contra-indicated; or d) were suffering
from neurological conditions which necessitated a resting
head up position. 
Metabolic computer Oxygen consumption was measured
using the Engstrom metabolic computer (EMC) which is a
microprocesser based instrument attached to the Engstrom
Elvira ventilator(a). The EMC consists of a microprocessor
and oxygen-sensing fuel cell that measures both the




is calculated as the difference between the product of the
inspiratory volume and FiO
2 
and the expiratory volume and
FeO
2
. Calibration and service of the EMC was performed
by the Biomedical Engineering Department at the Austin
and Repatriation Medical Centre according to
manufacturers’ guidelines for routine service. Prior to each
occasion of use, the barometric pressure was checked with
the Bureau of Meteorology and programmed into the
ventilator. Calibration of the oxygen sensors of the EMC to
FiO
2
= 1 and 0.4 gas mixture was also performed. The
computer was considered calibrated when the difference
between the O
2 
sensing fuel cells and the ventilator’s FiO
2
was within 0.3%. The validity and accuracy of
measurement of VO
2
by the EMC has been previously
established in a laboratory setting against a system
developed by Nunn et al (1989) for the absolute calibration
of indirect calorimeters, under the condition of mechanical
ventilation and increased O
2
concentrations. This same
system was utilised to test the reliability of the EMC
against two other commercially available systems and
demonstrated the lowest relative error in measurement of
1.4% (Makita et al 1990). 
Procedure All subjects were randomly allocated to a
treatment sequence (Figure 1). The randomisation process
involved picking a letter from an otherwise sealed envelope
denoting treatment sequence. Treatment A involved
physiotherapy treatment which included gravity assisted
drainage with the foot of the bed elevated to 35 to 45
degrees from the horizontal plane with the patient lying on
the side, ventilator hyperinflation (VHI), and suctioning.
The entire duration of physiotherapy treatment was 20
minutes and contained no more than three suction passes.
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Baseline 1 = 10 minutes steady state VO2
Baseline 2 = within 5% VO2 of Baseline 1
Baseline 3 = within 5% VO2 of Baseline 2
MABP = Mean arterial blood pressure measured for 20
minutes of intervention.
= Measure of cardiac index
Figure 1. Flow chart of the experimental procedure.
Oxygen saturation was continuously monitored during
treatment using pulse oximetry(b). Ventilator hyperinflation
involved reducing the ventilator’s respiratory rate to six,
decreasing the inspiratory flow to 20 L/min, incorporating
a square wave form and increasing the patient’s tidal
volume by 100 mL increments until a peak inspiratory
pressure of 40 cmH
2
O was achieved. Six mechanical
breaths were delivered to this pressure and the patient was
then returned to the original ventilatory parameters and
allowed to rest for a period of 30 seconds when the
procedure was repeated. In total, the treatment consisted of
six sets of six VHI breaths which were all performed by the
same investigator. Pre-oxygenation to FiO
2
= 1 was not
performed prior to suctioning, as the measurement of VO
2
becomes unreliable with variation in FiO
2.
. Endotracheal
suction was performed using size 12 Baxter catheters(c).
Treatment B involved turning the patient onto the side and
leaving him or her undisturbed for 20 minutes. Patients
were positioned onto the same side for both Treatment A
and Treatment B. The position was decided upon by
consultation between the radiologist, intensive care
physician and treating physiotherapist. If bibasal opacities
were present, patients were turned to the side to which they
were next due in accordance with their pressure care
routine.
Measurement Once the treatment sequence was decided,
the patients were started on the Elvira ventilator with
ventilatory parameters remaining unchanged. The patient
was placed in the supine position and allowed to stabilise
on the ventilator for a period of one hour prior to the
commencement of the data collection. Initial measurement
involved recording of minute-by-minute VO
2
whilst the
patient lay undisturbed for a period of 10 minutes. This was
called Baseline 1. There were no restrictions regarding
administration of sedative, analgesic or vasoactive drugs or
the provision of essential care throughout this period.
Measures of CI were made using the pulmonary artery
catheter(c). Three measures of cardiac output were taken,
the first was discarded and the average of the second and
third measure was divided by the body surface area of the
patient and recorded as the CI. These measures of CI were
performed immediately on completion of Baseline 1 by the
attending nurse. The patient was then positioned into side
lying and another set of CI measures was performed prior
to the commencement of the pre-determined phase of
intervention. During treatment, minute-by-minute
measurements of VO
2
and MAP from an indwelling arterial
line(d) were recorded and on completion of treatment, CI
was re-measured with the patient in the same side lying
position. Patients were then returned to the supine position
and lay undisturbed until they recovered to within 5% of
the Baseline 1 VO
2
, which was called Baseline 2. Once this
was achieved, CI was re-measured and subjects were turned
onto the same side. Measurement followed the same
sequence as previously described and the alternate
treatment was performed. When the second phase of the
intervention was complete, patients were returned to the
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Table 1. Demographic data.
Age Condition Gender APACHE II Baseline VO2 Sedation Inotropic support(mL/min) (mg/hr) (µg/min)
63 MVR M 14 364.1 Nil Noradrenalin 3
75 Septic shock M 10 261.0 Morphine 1 Noradrenalin 2
Dopamine 21*
75 AAA rupture M 24 223.6 Morphine 3 Noradrenalin 31
71 Respiratory M 19 479.2 Morphine 2 Noradrenalin 6
failure
74 Septic shock M 14 678.6 Morphine 1 Noradrenalin 10
Midazolam 1 Dopamine 4.9*
73 Septic shock F 20 445.2 Morphine 2 Noradrenalin 22
Midazolam 2
54 Septic shock M 16 342.1 Morphine 3 Noradrenalin 14
Midazolam 1
75 Pancreatitis M 19 606.4 Morphine 2 Noradrenalin 8
Midazolam 2
54 Partial M 18 328.0 Morphine 1 nil
gastrectomy
67 CAGS M 24 387.2 Morphine 5 nil
Midazolam 5
Haloperidol 3
*µg/kg/min. APACHE, Acute Physiological Health Evaluation Score. MVR, mitral valve replacement. AAA, aortic abdominal
aneurysm. CAGS, coronary artery graft surgery.
supine position and the length of time required for the
patients to return to within 5% of Baseline 2 was recorded,
which was called Baseline 3. The same physiotherapist
performed each treatment whilst an assistant recorded the
data.
Statistical analysis The values for VO
2
were averaged for
each phase of the study to give a VO
2
mean for both
physiotherapy treatment and side lying. The VO
2
mean was
used as it reflects the average metabolic cost of each
intervention and has been utilised extensively in previous
literature (Cohen et al 1996, Harding et al 1993 and 1994,
Klein et al 1988, Swinamer et al 1987, Weissman et al
1984, Weissman and Kemper 1993). Peaks in VO
2
were
also measured in order to determine whether any specific
components of intervention involved greater metabolic
demand and these were presented as a percentage rise in
VO
2
compared with corresponding previous baseline
measures. The variables VO
2
mean, MAP and CI were
analysed using two way analysis of variance with two
repeated measures. Time to recovery of baseline VO
2
was
analysed using a one way analysis of variance. The level of
significance was set at p < 0.05. Data are expressed as
mean difference (95% confidence limits for the difference).
Results
Nine males and one female fulfilled the study inclusion
criteria. The mean age of the patients was 68 years with a
range of 54 to 75 years. The mean FiO
2
delivered was 0.47
with a range 0.4 to 0.6. The mean Acute Physiological and
Chronic Health Evaluation score (APACHE II) was 17.8
with a range of 10 to 24. The descriptive data for patients
are presented in Table 1. 
No patients required an increase in inotropic support
during the course of the study. Only one patient required a
1 mg bolus dose of Midazolam throughout the testing
procedure. This was administered following the turn into
side lying, prior to physiotherapy treatment.
There was no significant difference in the increase in VO
2
mean during 20 minutes of undisturbed side lying
compared with 20 minutes of physiotherapy treatment from
baseline (F
(1,9)
= 2.19, p = 0.17). The mean difference in
VO
2
between physiotherapy treatment and side lying was
14.8 (-8.8 to 38.4) mL/min.
During the study, increases in VO
2
sustained for less than
one minute were observed in all patients and were
classified as transient. In 50% of cases, these occurred as a
result of turning from supine into side lying and involved a
mean transient increase of 39% in VO
2
(Table 2). In four
patients, suction induced a mean 50% transient increase in
VO
2
, whilst in one patient, physiotherapy treatment
produced a 61% increase in VO
2
.
Time to recovery to within 5% of baseline VO
2
measured
with the patient in the supine position was achieved within
seven minutes for all subjects. There was no significant
difference in recovery time between side lying or
physiotherapy treatment (F
(1,9)
= 0.248, p = 0.63). The mean
difference was -0.6 (-1.8 to 3.0) minutes.
There were no significant differences in the cardiovascular
parameters CI (F
(1,9)
= 0.65, p = 0.44) or MAP 
(F
(1,9)
= 0.004, p = 0.95) during physiotherapy treatment
compared with undisturbed side lying. The mean difference
in CI was 0.20 (-0.4 to 0.4) L/min/m2 and the mean
difference for MAP was 1 (-2.1 to 4.1) mmHg.
Discussion
The benefits of physiotherapy treatment for intubated and
ventilated patients have been previously documented
(Ciesla 1996,  Hodgson et al 2000, Jones et al 1992,
Mackenzie et al 1980, Mackenzie and Shin 1985,
Mackenzie 1989, Ntoumenopoulos and Greenwood 1996,
Stiller et al 1990 and 1996), however there have also been
reports of concerning metabolic side effects (Cohen et al
1996, Harding et al 1994, Klein et al 1988, Weissman and
Kemper 1993). Because of methodological and statistical
inconsistencies, these earlier studies failed to demonstrate
conclusively that physiotherapy treatment increases
metabolic demand as measured by VO
2 
in the ICU. The
findings of this study suggest that physiotherapy treatment
does not increase the metabolic or cardiovascular demand
of the patient population studied in this trial.
The resting VO
2
of the current patient group appeared
somewhat higher than that reported in previous literature. It
is possible that the current patients were a more severely ill
sample. However APACHE II scores were not routinely
recorded in earlier studies to allow comparisons (Cohen et
al 1994, Harding et al 1993 and 1994, Klein et al 1988,
Weissman and Kemper 1993). Patients in this study
received relatively low doses of sedative drugs which
should not have masked any induced metabolic or
cardiovascular responses (Harding et al 1993 and 1994,
Klein et al 1988). 
The physiotherapy treatment performed in this study lasted
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Table 2. Activities associated with greatest overall % rise
in VO2 throughout the experimental procedure.











substantially longer than that reported in previous literature
(Cohen et al 1994, Harding et al 1993 and 1994, Klein et al
1988, Weissman and Kemper 1993). One of the key
methodological differences between this study and earlier
research was that VO
2
was allowed to return to baseline
levels before proceeding with the next intervention. In
allowing this recovery time it was hoped to isolate the
effects of turning the patient from that of active
physiotherapy treatment and reduce possible carry-over
effects. Earlier research reported increases in VO
2 
of
between 31% and 47% (Horiuchi et al 1997, Swinamer et
al 1987) associated with repositioning the patient. The
current study concurs with these findings, with an increase
in VO
2
of 39% observed in 50% of the patients upon
positioning into side lying. These peaks in VO
2
were,
however, not sustained and there was no significant
increase observed in VO
2
mean. As previous investigators
(Cohen et al 1994, Harding et al 1993 and 1994, Klein et al
1988, Weissman and Kemper 1993) did not allow a
recovery period and reported an increase in VO
2
mean of up
to 52% (Weissman and Kemper 1993) it is possible that the
multiple patient turns in rapid succession may have
contributed to a cumulative rise in VO
2
mean rather than
being an outcome due to physiotherapy treatment per se.
The findings of the current study therefore suggest that the
metabolic and cardiovascular effects of turning a patient
into a side lying position were greater than the
physiological stress incurred by the addition of
physiotherapy treatment. These conclusions support the
work of Horiuchi et al (1997) who found that the rise in
VO
2
associated with physiotherapy treatment could be
explained by turning the patient into a side lying position.
Endotracheal suctioning produced peaks in VO
2
which
amounted to a mean 56% increase from baseline. In
addition, during physiotherapy treatment six of the 10
patients recorded the highest VO
2
during endotracheal
suctioning. This was not a surprising result, as the stressful
effects of this procedure are well documented (Paratz 1992,
Young 1984). It must also be remembered that the patients
were suctioned in the gravity-assisted drainage position.
This may have further increased the metabolic stress and
may have required an increased effort by the patient to
cough, given the altered diaphragmatic and abdominal
muscle position. Previous studies have failed to separate
the effects of physiotherapy treatment and endotracheal
suctioning (Cohen et al 1994, Harding et al 1993 and 1994,
Klein et al 1988, Weissman and Kemper 1993). Based upon
the findings of this study, this may have influenced their
conclusions regarding the metabolic demands of
physiotherapy treatment. The observed peaks in VO
2
associated with suctioning were not sustained. However,
repetitive suctioning, which is often required in the clinical
situation, may alter this finding. In critically ill patients
with copious pulmonary secretions, pre-oxygenation and
recovery time between suction passes may be important
strategies in minimising the possible metabolic side effects
of this procedure. However it must be remembered that,
although included in a physiotherapy treatment session,
suctioning is part of the routine nursing care of the patient.
The metabolic effects of suctioning should not be attributed
to physiotherapy treatment alone.
The metabolic effects of VHI and MHI have not previously
been reported. A peak increase in VO
2
was observed in one
patient during physiotherapy treatment that included VHI.
One of the aims of hyperinflation is the mobilisation of
pulmonary secretions (Singer et al 1994, Tweed et 1993,
Webber and Pryor 1993). The effect of mobilising
secretions often results in the patient coughing at times
during the procedure and it was therefore expected that
there may be transient increases in VO
2
associated with this
treatment technique. In addition, even when the patient is at
rest in side lying, transitory increases in VO
2 
occur. This
may be a response to anxiety, agitation, anticipation or
voices at the bedside (Weissman et al 1984). For these




There appeared to be no significant adverse cardiovascular
effects of the physiotherapy treatment as measured by CI
and MAP when applied in this patient population. Neither
the CI nor the MAP of the patients studied altered
significantly from baseline during either physiotherapy
treatment or positioning in side lying. This was of interest
as previous literature has reported variable effects of
hyperinflation on cardiovascular stability with some
investigators reporting a 50% reduction in cardiac output
with MHI (Laws and McIntyre 1969) whilst others report
an increase in cardiac output (Preusser et al 1988, Stone et
al 1989 and 1991). The stability of cardiovascular status
observed in this study may have been the result of the
inherent differences between VHI and MHI, such as slower
incremental rises in tidal volume.
The time to recovery to within 5% of baseline VO
2
occurred within seven minutes of completion with either
intervention. This time was not significantly different
between the side lying phase or the physiotherapy
treatment component. This generally supports the findings
of previous literature (Cohen et al 1994, Harding et al 1993
and 1994, Klein et al 1988, Weissman and Kemper 1993).
Although these authors stated no time frame for this
recovery, their findings, and those of the current study,
provide evidence that any increase in VO
2
induced by
physiotherapy treatment (or turning into side lying) is not
sustained and is reversible in this patient population. 
In this study, both the mean difference in VO
2 
(14.8
mL/min) and the upper confidence limit (38.4 mL/min)
were small. Therefore we are confident that the increase in
VO
2
mean associated with physiotherapy treatment is not
clincally relevant (Goodman and Berlin 1994). The results
are in contrast with previous research (Cohen et al 1994,
Harding et al 1993 and 1994, Klein et al 1988, Mathews
and Weissman 1990, Weissman and Kemper 1993),
although few of these studies adequately investigated the
effects of physiotherapy treatment in isolation. It would
also have been preferable to employ MHI rather than VHI,
as physiotherapists generally utilise MHI in clinical
practice in Australia. However, VHI has been shown to be
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as effective in improving short term physiological
outcomes as MHI (Berney and Denehy 2002). The use of
VHI due to technical reasons in this study is therefore
supported.
Conclusions
Physiotherapy treatment per se does not appear to have
adverse effects on VO
2
, CI and MAP in stable critically ill
patients. Associated activities such as positional changes or
suctioning may be more important, although transient,
causes of such changes. These activities are part of routine
care and occur independently of the physiotherapy
treatment. Knowledge of the aetiology and severity of such
changes may be useful in guiding practitioners with the
selection of appropriate interventions in the critically ill.
Footnotes (a)Gambro Engstrom AB, Bromma, Sweden. 
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